Next Article in Journal
Hyperthermia Enhances Efficacy of Chemotherapeutic Agents in Pancreatic Cancer Cell Lines
Next Article in Special Issue
Coaxial Synthesis of PEI-Based Nanocarriers of Encapsulated RNA-Therapeutics to Specifically Target Muscle Cells
Previous Article in Journal
Oncogenomic Changes in Pancreatic Cancer and Their Detection in Stool
Previous Article in Special Issue
Microtube Array Membrane Hollow Fiber Assay (MTAM-HFA)—An Accurate and Rapid Potential Companion Diagnostic and Pharmacological Interrogation Solution for Cancer Immunotherapy (PD-1/PD-L1)
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Osteoblast Attachment on Titanium Coated with Hydroxyapatite by Atomic Layer Deposition

1
Department of Anatomy and Cell Biology, Institute of Cancer Research and Translational Medicine, Medical Research Center, University of Oulu, P.O. Box 5000, 90014 Oulu, Finland
2
Department of Chemistry, University of Helsinki, P.O. Box 55, 00014 Helsinki, Finland
3
Department of Prosthetic Dentistry and Stomatognathic Physiology, Institute of Dentistry, University of Turku, 20520 Turku, Finland
*
Author to whom correspondence should be addressed.
Biomolecules 2022, 12(5), 654; https://doi.org/10.3390/biom12050654
Submission received: 16 March 2022 / Revised: 25 April 2022 / Accepted: 27 April 2022 / Published: 29 April 2022
(This article belongs to the Special Issue Biomolecules and Materials Based Approaches in Biomedical Field)

Abstract

:
Background: The increasing demand for bone implants with improved osseointegration properties has prompted researchers to develop various coating types for metal implants. Atomic layer deposition (ALD) is a method for producing nanoscale coatings conformally on complex three-dimensional surfaces. We have prepared hydroxyapatite (HA) coating on titanium (Ti) substrate with the ALD method and analyzed the biocompatibility of this coating in terms of cell adhesion and viability. Methods: HA coatings were prepared on Ti substrates by depositing CaCO3 films by ALD and converting them to HA by wet treatment in dilute phosphate solution. MC3T3-E1 preosteoblasts were cultured on ALD-HA, glass slides and bovine bone slices. ALD-HA and glass slides were either coated or non-coated with fibronectin. After 48h culture, cells were imaged with scanning electron microscopy (SEM) and analyzed by vinculin antibody staining for focal adhesion localization. An 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT) test was performed to study cell viability. Results: Vinculin staining revealed similar focal adhesion-like structures on ALD-HA as on glass slides and bone, albeit on ALD-HA and bone the structures were thinner compared to glass slides. This might be due to thin and broad focal adhesions on complex three-dimensional surfaces of ALD-HA and bone. The MTT test showed comparable cell viability on ALD-HA, glass slides and bone. Conclusion: ALD-HA coating was shown to be biocompatible in regard to cell adhesion and viability. This leads to new opportunities in developing improved implant coatings for better osseointegration and implant survival.

1. Introduction

Global ageing and diverse accidents occurring in free time activities have caused an increased demand for implantable devices for repairing human tissues. For bone implants, the attachment of the implant to the bone tissue along with new bone formation, termed osseointegration, is extremely important. Failed osseointegration, biomechanical changes and micromotions over time can lead to implant loosening, causing a need for revision surgery [1,2].
Bone implants are commonly made of metals, ceramics or polymers and often their biocompatibility is enhanced by surface modifications. Cellular attachment is the first and most indispensable event in osseointegration and it affects the overall survival of the implant. Before the cells attach to the implant surface, it becomes coated with endogenous proteins. To avoid random coating with various proteins present in the body, and thus improve cellular attachment, several extracellular matrix proteins, such as collagen, laminin and fibronectin, have been utilized to synthetically coat the implants before implantation [3,4].
Titanium (Ti) and Ti-based alloys have for long been used to treat hard-tissue injuries, as Ti has many advantages over other metal implants. For instance, Ti is non-toxic, resistant to corrosion and has good mechanical properties [2,5]. Hydroxyapatite (HA; Ca10(PO4)6(OH)2) coating of Ti implants is a surface modification that has been shown to improve osseointegration [2,5,6,7,8,9,10,11]. As the natural bone and teeth mineral, HA has been found to be advantageous for coating bone implants [12]. Bone can directly grow into HA coating, creating a stable connection to the implant [11,13,14,15,16]. In addition to better osseointegration, the HA coating prevents the release of metal particles from the implant [17,18,19].
Besides being beneficial for bone growth within the implant, the HA coating seems to be a target for degradation over time [20,21,22,23]. Interestingly, the degradation does not affect the fixation of the implant, as in many cases the HA has been totally replaced by new bone [20,21]. The mechanism behind this phenomenon is osteoclast-mediated bone resorption and subsequent bone remodeling producing the new bone [20,22,24,25,26,27]. In fact, some studies provide evidence that the initial osteoclast activity is a prerequisite for bone formation around the implant [28,29,30,31]. An important mediator of osteoclast differentiation and resorption is the vast macrophage population around the implant, resulting from the insertion of a foreign body into the tissue. These macrophages or foreign body cells can either produce osteoclast activating molecules or serve as precursors for differentiating osteoclasts [32,33,34,35,36].
HA coatings can be made by various methods, such as the sol-gel, plasma spraying, laser ablation and sputter coating. However, these methods are not always ideal since they might need a very high processing temperature and tend to produce coatings with unfavorable properties such as brittleness and flaking or cracking [37,38,39]. In addition, many of these methods are expensive and cannot be used to coat complex-shaped implants with a uniform coating thickness [37]. One method to overcome these problems is atomic layer deposition (ALD), which can coat complicated three-dimensional surfaces with a thin conformal layer. In the ALD process alternating pulses of gaseous precursors deposit a thin layer on a substrate via self-limiting reactions. The coating can be made layer by layer in nanometer scale, which is difficult with other methods [40].
Only a few studies have been conducted concerning cellular activities on surfaces made with the ALD technique. Recent studies utilized ALD in preparing TiO2 films and showed that the coating improved human osteoblast C-12720 [41], MG-63 [42] and murine osteoblast lineage MC3T3 cell [43] adhesion, proliferation and differentiation [44], but inhibited these activities in fibroblasts [41] and had an inhibitory effect on osteoclast invasion [43]. Motola et al. [45] coated Ti and Ti nanotube surfaces with an additional ALD TiO2 coating and reported increased WI-38 fibroblast and MG-63 osteoblast growth on the coated surfaces. Zemtsova et al. [46] produced a titano-organic coating from TiCl4 and propargyl alcohol with ALD and showed increased differentiation of MC3T3 cells and better osseointegration in a rabbit model. Liang et al. [47] observed enhanced HA formation in simulated body fluid on ALD alumina (Al2O3) and TiO2 coatings, and demonstrated that NIH/3T3 fibroblasts attached to the coatings. Radtke et al. [48] showed that murine L929 fibroblasts attached to Ti6Al4V samples coated with Ti nanotubes and ALD-HA, and that cell proliferation was increased on the coated surfaces compared to non-coated surface and the surface without the Ti nanotube layer. In addition, thin films of zirconia produced by ALD have been shown to increase the viability and differentiation of MC3T3 cells [49,50]. A recent review article by Astaneh et al. [51] summarized the physical and clinical properties of ALD coated dental materials.
We have utilized ALD in preparing a nanocrystalline HA coating on Ti substrate by converting ALD-CaCO3 to HA by a chemical treatment in dilute phosphate solution [52]. We have also recently tested the mechanical properties of different versions of this coating by tensile adhesion and scratching tests [53]. The coatings were found to be intact and suitable for further investigation, such as cell attachment and biocompatibility. Although we showed in the first study that human bone marrow-derived cells can be cultured on this nanocrystalline HA coating, we did not characterize cell adhesion thoroughly with cell biological methods.
The purpose of this study was to characterize cell attachment on the nanocrystalline HA coating generated on Ti samples with the ALD method. We were interested in whether the osteoblastic cell line MC3T3-E1 cells would attach to the surface with similar focal adhesions as they attach to glass slides and bone, and whether the cells would have normal morphology. In addition, we tested whether fibronectin (FN) coating of the samples affects cell adhesion. The hypothesis that the coating would be biocompatible concerning cellular attachment would aid in developing these thin HA coatings with beneficial properties.

2. Materials and Methods

2.1. Preparation of Nanocrystalline HA Coating (ALD-HA) on Ti Substrates with ALD Method

The HA coatings were made on Ti substrates as described in [52,53]. The substrate for ALD HA coating was a 1 mm thick titanium sheet (Grade 2, ASTM B265 specification, William Gregor Ltd., London, UK). The ALD coating was started by depositing a thin film of CaCO3 in a F-120 ALD reactor (ASM Microchemistry Ltd., Helsinki, Finland) with nitrogen carrier and purging gas. The CaCO3 films were deposited using the Ca(thd)2-O3 process previously reported in the literature [54]. Ca(thd)2 (Volatec Oy, Porvoo, Finland) was evaporated at 188 °C and O3 was generated from O2 (99.9999%) with a Wedeco Ozomatic Modular 4 HC Lab ozone generator. Pulses and purges of 1 s were used for all precursors. The depositions were conducted at 250 °C. Conversion of CaCO3 to HA was achieved by using 0.2 M (NH4)2HPO4 (Merck, 99%) solution at 95 °C. After conversion, the samples were rinsed with deionized water and blown dry with compressed air. Samples were produced with 4000 cycles. A manual plate cutter (Bernardo PTS 1050 S Manual disc cutter, Linz, Austria) was used for cutting the ALD coated titanium plates. The Ti plate was firmly placed in a disc pressing to keep it in place during the cutting process. Then the plate was cut to produce 1 cm2 square-shaped size discs. Before cell culture, the samples were soaked in 70% ethanol for 10 min and air-dried.

2.2. MC3T3-E1 Cell Culture

Osteoblastic MC3T3-E1 cells were obtained from Merck Life Science Oy, Darmstadt, Germany and cultured in α-MEM (Gibco; Thermo Fisher Scientific, Waltham, MA, USA) without ascorbic acid but containing 10% fetal bovine serum (FBS) (Biowest, Riverside, MO, USA), 100 IU/mL penicillin and 100 µg/mL streptomycin and 24 mM Hepes buffer (Sigma-Aldrich, St. Louis, MO, USA) at +37 °C (5% CO2, 95% air). Fibronectin coating of cover glasses and ALD-HA was performed using phosphate buffered saline (PBS) with 10 ng/mL FN (Sigma-Aldrich). A volume of 200 µL of the dilution was incubated on the samples for 2 h at +37 °C, after which the samples were dried. Before cell seeding, all samples were soaked in cell culture medium for 10 min. For culturing on cover glasses, bone slices or ALD-HA samples, 10,000 cells/cm2 were seeded on the samples in 24-well plates (Cellstar; Greiner Bio-One, Kremsmünster, Austria) and cultured for 48 h. Sonicated bovine cortical bone slices (0.28 cm2) were obtained from Lehenkari Consulting, Oulu, Finland.

2.3. Focal Adhesion Staining

The cells were fixed and permeabilized with 4% paraformaldehyde (PFA)-0.3% Triton X-100-PBS for 10 min and blocked with 0.2% bovine serum albumin (BSA) (Sigma-Aldrich) for 30 min at room temperature (RT). Focal adhesions were stained with 1:100 diluted monoclonal anti-vinculin (Nordic BioSite Oy, Helsinki, Finland) for 1 h at RT and secondary antibody goat anti-mouse Alexa 488 (2 mg/mL stock diluted 1:100 in PBS, Molecular Probes; Thermo Fisher Scientific) for 1 h at RT. The actin cytoskeleton was stained with TRITC-conjugated phalloidin (0.1 mg/mL stock diluted 1:100 in PBS; Sigma-Aldrich) for 20 min at +37 °C. Nuclei were stained with Hoechst 33258 (1 mg/mL stock diluted 1:800 in PBS; Sigma-Aldrich) for 10 min at RT. The cover glasses were mounted in ImmuMount (Thermo Fisher Scientific) and ALD-HA samples and bone slices were mounted in 70% glycerol-PBS. The cells were viewed with Leica TCS SP8 confocal with a DMI8 microscope (Leica, Wetzlar, Germany) using LAS X 3.5.2 acquisition software (Leica). The objective used was an HC PL APO CS2 63 x/1.40 Oil. Samples were imaged with 405, 499 and 551 nm solid-state lasers with emission windows at 410–494, 509–556 and 561–754 nm, respectively. The pinhole was set to Airy 1 and scan speed to 600 Hz. Images were acquired with 1.48 zoom (pixel size 0.059 µm). Maximum intensity projections (MIP) were created from the Z-stacks.

2.4. Field Emission Scanning Electron Microscopy (FESEM)

The ALD-HA samples were dehydrated in ascending ethanol series and dried with a critical point drying equipment K850 (Quorum Technologies, Lewes, UK). Samples were coated with 5 nm platinum by Q150T ES sputter coater (Quorum Technologies, Lewes, UK) and viewed with Sigma HD VP FE-SEM (Carl Zeiss Microscopy GmbH, Oberkochen, Germany). FESEM images were taken with 5.0 kV voltage.

2.5. Cell Morphology Measurement

The average aspect ratios (major axis/minor axis) of the cells (n ≥ 5) were measured from confocal microscopy images with QuPath bioimage analysis software, version 0.3.2 (University of Edinburgh, Edinburgh, UK) from the snapshot sent to Image-J, version 1.53i (NIH, Bethesda, MD, USA).

2.6. Cell viability Assay with MTT

After 48 h culture, the medium was removed, fresh medium with 0.5 mg/mL 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide (MTT; Sigma-Aldrich) dye was added to the wells and incubated at +37 °C for 4 h. Thereafter, the medium was replaced with an equal volume of dimethyl sulfoxide (DMSO; Merck, Germany) and mixed. Cell viability was assessed by measuring absorbances at wavelengths 550 and 650 nm (background) with Victor 2 multilabel counter (Perkin Elmer/Wallac, Turku, Finland). Cell viability on bone slices and ALD-HA samples was compared to cover glasses, which were treated as controls by setting their viability to 100%.

2.7. Statistical Analysis

All experiments were done with groups of n ≥ 3 and repeated with three independent samples. Statistical analyses were performed with SPSS version 26 (SPSS Inc., Chicago, IL, USA). The normality of the response variables was tested with the Shapiro–Wilk test and histogram visualization. Since the response variables were not normally distributed, statistical differences between the test groups were evaluated using the Kruskal–Wallis test, and a comparison between groups was performed using Mann–Whitney U-test. The graphical presentation of the results was created with OriginPro 9.7 software (OriginLab, Northampton, MA, USA). p < 0.05 was considered significant. Data are shown as mean ± SEM.

3. Results

3.1. MC3T3 Cells Attached to ALD-HA

MC3T3 cells were cultured on cover glasses, ALD-HA, FN-coated ALD-HA and bone slices for 48 h and imaged with FESEM. The cells on all samples were spread uniformly, their morphology was normal and the cells were attached to the surfaces (Figure 1A). On cover glasses, the cell morphology was flatter compared to ALD-HA and bone. On ALD-HA and bone, the cells seemed to attach to the surface with thin focal adhesion-like structures at the actin cytoskeleton protrusions or at the tips of long filopodia (Figure 1B). Concerning the cell morphology, the average aspect ratios (major axis/minor axis) of the cells were 1.4 ± 0.14 on cover glass, 2.3 ± 1.12 on ALD and 6.7 ± 2.33 on bone slice. The results indicate that the cell morphology on cover glass was relatively circular, whereas on ALD-HA and bone the morphology was more elongated.

3.2. MTT-Results Confirmed the Viability of Cells Cultured on ALD-HA

We tested whether the cell viability on ALD-HA was comparable to viability on cover glasses and bone. Cover glasses were used as a control, and the results showed that on bone slices the viability was significantly higher compared to cover glasses (p < 0.001). In contrast, on ALD-HA the viability was significantly lower (p < 0.001) (Figure 1B). The results show that there are viable cells on the ALD-HA samples. The lower viability percent compared to cover glasses and bone depicts that the cell number is lower on ALD-HA, as the MTT test values are directly proportional to the number of viable cells on the samples.

3.3. Thin Focal Adhesion-Like Structures Were Observed in MC3T3-Cells Cultured on ALD-HA

When MC3T3-E1 cells were cultured on cover glasses, the vinculin staining showed small dot-like structures on the edges of the cells representing the cell attachment with focal adhesions (Figure 2). In addition, constant cytoplasmic vinculin was observed. Coating the cover glass with FN did not affect the vinculin localization or cell morphology. When cells were cultured on ALD-HA or bone slices, the vinculin staining was slightly dimmer, but thin focal adhesion-like structures were observed on the edges of the cells. As with cover glasses, vinculin was also present in the cytoplasm, and the FN coating did not affect vinculin localization or cell morphology on cells cultured on ALD-HA. Thus, the FN coating did not seem to have remarkable benefits concerning cell adhesion. In regard to actin stress fiber staining, the cells on ALD-HA coated surfaces were lacking the stress fibers nearly completely, whereas on cover glass and bone the stress fibers were clearly distinguishable.

4. Discussion

We have previously shown that human bone marrow-derived cells can be cultured on nanocrystalline HA-coated titanium substrates prepared with the ALD method [52]. In addition, in our tests, the coating was stable [53], and the bone marrow-derived monocytes could fuse into multinuclear cells on the coating, as they do on natural bone slices [52].
Several studies have been made to investigate bone cell attachment to HA. For instance, it has been shown that rat bone marrow mesenchymal stem cell attachment, cell viability and ALP expression were higher on a polycaprolactone-polytetrahydrofuran-HA composite scaffold compared to the HA-deficient composite [55]. Other studies showed that HA coating on TiO2 nanotubes [56,57] and titanium disks [58] supports osteoblast lineage MC3T3 cell attachment, proliferation and differentiation. Polylactic acid (PLA)-HA composite films were also superior to neat PLA in the promotion of MC3T3-E1 cell attachment as well as in the induction of focal adhesions dose dependently [59]. Opposite results of the benefits of HA coating have also been observed, as Kobayashi et al. [60] showed that HA dispersed into a Ti-based composite inhibited MC3T3 adhesion and proliferation in a concentration-dependent manner.
This is the first study characterizing in detail the cell attachment on HA coating made with the ALD method. In addition to studying the cellular attachment to ALD-HA, we wanted to study if FN coating would improve the attachment of MC3T3 cells on the surface. The initial attachment to a surface occurs with a multiprotein complex, focal adhesion, including, among others, vinculin, talin and paxillin [61]. Immunofluorescence staining of these proteins can be used to localize focal adhesions. We were able to show thin focal adhesion-like structures based on vinculin immunofluorescence in MC3T3 cells cultured on ALD-HA coating, as well as on ALD-HA coating additionally treated with FN. The cell morphology and spreading were similar on both surfaces, indicating that the additional FN layer did not enhance the biocompatibility of the surface in relation to cell attachment. Our results are to some extent contrary to earlier studies, where better MC3T3 cell attachment [62], higher viability [63] and enhanced differentiation [64,65] on FN-coated titanium surfaces compared to bare titanium was observed. However, these studies were made with FN-coated titanium samples without the additional HA layer between the Ti and FN. Although Pramono et al. [65] showed the benefits of FN-coating for MC3T3 attachment, they did not detect differences in the cell morphology between the coated and non-coated surfaces, which supports our observation of the similar morphology on different surfaces. Further, in a continuation to the study by Pugdee et al., Yoshida et al. [66] noticed that FN-coating of Ti possibly enhances the initial adhesion, but not proliferation or activity of MC3T3 cells. The authors point out that FN is nevertheless produced in cell culture, and therefore the FN-coating might not offer remarkable benefits for cellular adhesion. In their study, the main changes in cell morphology were caused by mechanical treatment (sandblasting) of the Ti surface, but not the FN-coating. As mentioned in the previous paragraph, in the article by Kobayashi et al. [60], HA in Ti-composite plates inhibited MC3T3 adhesion and proliferation, but the coating of the plates with FN decreased the inhibitory effect of HA. Similar to the study by Yoshida et al. [66], the main changes in the cellular activities were caused by the manufacturing process (sintering temperature) of the samples instead of the FN coating [60]. Also, Noh et al. [67] showed that although FN improved adhesion of MC3T3 and monocyte-macrophage lineage Raw 264.7 cells on Ti disks, a more pronounced improvement in the adhesion was obtained by increasing the surface roughness. Concerning osseointegration properties of HA-FN coating, it was shown that an HA-FN-coated dental implant in a canine model did not improve the results compared to non-coated implants [68].
The surface roughness of Ti and its alloys is well known to affect cellular attachment and osseointegration of implants [69,70,71], and several studies have shown that a combination of micro- and nanoscale surface roughness leads to optimal results [42,72,73,74,75,76,77,78]. Several studies have examined the optimal surface roughness for MC3T3 adhesion and differentiation. Some studies have found that roughness in the micrometer range (0.5–2.5 µm) is preferable to smoother or rougher surfaces [63,79,80,81,82]. Iwaya et al. [83] reported no differences in MC3T3 cell proliferation and collagen production between Ti disks with a surface roughness from 0.34 µm to 2 µm. Still, this roughness range fits well to the aforementioned micrometer range that was found optimal in other studies. Regarding the nanometer range modifications, 100 nm roughness has been reported to inhibit MC3T3 attachment, spreading and differentiation compared to smooth Ti surface [84,85]. On the contrary, on Ti-alloy coated with Ti nanotubes and ALD-HA, a roughness of 135 nm was found to be optimal for fibroblast adhesion and proliferation compared to smoother surfaces [48]. In addition, combinations of micro- and nanoscale roughness have also been suggested to be favorable for MC3T3 adhesion and differentiation [46,86,87]. However, as Nobles et al. [71] and Wennerberg et al. [69] remark, the aforementioned studies have utilized a wide range of surface features and modification techniques, leading to difficulties in interpreting the results, i.e., whether they are caused by the surface characteristics or the techniques they were manufactured by.
Regarding the observation of the focal adhesion-like attachment of the cells on the ALD-HA coating, we did not detect increased vinculin expression on HA-coating, which was shown on calcium and phosphate ion-modified Ti-coating by Sunarso et al. [88]. In their study, vinculin expression on the Ca-P-Ti-coating was compared to pure Ti-disks, whereas our control stainings were made on glass slides, which presumably explains the differences. In conclusion, several studies have been made with various mechanical treatments and surface modifications of HA-coated titanium, and therefore the studies have produced diverse results of the events occurring on the cellular level.
The observation that the focal adhesions on ALD-HA did not stain as brightly and in spot-like fashion as on glass slides could be explained by the very large surface area of the HA coatings. The glass slide is very smooth and dense, leading to the formation of thick concentrated adhesion structures, compared to the rough surface of the HA coating, where the adhesion structure must cover a larger area three-dimensionally. This might create focal adhesions difficult to visualize with immunofluorescence methods. A similar structure develops on bone slices having a rougher saw cut surface, as the vinculin staining on bone slices resembled closely the staining on ALD-HA. The observation of the staining being similar on the bone slice and ALD-HA might indicate that the ALD-HA surface has a huge surface area related to plate-like HA crystals pointing out from the surface. Based on the results of this study, we assume that the HA nanocrystals provide a sufficient nanorough adhesive surface for cell adhesion. In addition, the actin stress fibers were much more numerous on cover glass and bone compared to ALD-HA. These findings are in line with the recent publication of Taniguchi et al. [89], where poorly oriented stress fiber organization was observed on rough zirconia surface indicating the importance of the surface topography.
The MTT test results confirmed that the cell viability on ALD-HA samples was comparable to the viability on cover glasses and bone slices, although on ALD-HA the viability was significantly lower when tested statistically. However, the MTT test results are directly proportional to the number of viable cells on the samples. Therefore, the results indicate that the cell number was lower on ALD-HA samples. The lower cell number is also visible in SEM and immunofluorescence images (Figure 1 and Figure 2). The observation that MC3T3 cells seemed to have higher cell viability on bone compared to cover glasses also results from higher cell numbers on bone, visible in Figure 1 and Figure 2. Bone appears to be the most favorable surface for the MC3T3 attachment, which can be explained by the osteoblast lineage origin of these cells. On plastic and cover glasses MC3T3 cells tend to form sheet-like monolayers [90,91], and a similar morphology has also been observed on bare and ECM protein-coated titanium surfaces [60,63,65,66,92]. Based on the aspect ratios of the cells in this study, we observed that the cells on cover glass were more round compared to the elongated cells on ALD-HA and bone. The morphology of MC3T3 cells on bone has not been studied in detail. Still, concerning osteoblast activity, including proliferation and collagen synthesis, Matsumoto et al. [93] have shown that sintered bone is a more favorable surface for MC3T3 cells compared to glass or HA-related material. This might explain the highest cell viability observed on bone slices in this study.
The morphology of the MC3T3 cells on the bone observed in this study bears a close resemblance to the morphology of the stromal cells from bone marrow. The stromal cell population often termed mesenchymal stem cells, is a heterogeneous cell population present in bone marrow [94,95] that can differentiate into osteoblasts, chondrocytes, adipocytes and fibroblasts [96,97]. Our previous studies showed that the stromal cells form a sheet-like structure on bone slices [98,99], simulating the canopy structure covering the bone remodeling sites in vivo [100]. The canopy is suggested to be formed either from bone lining cells [100] or from the bone marrow sac cells, which are stromal cells located above the bone lining cell layer on the endosteal side of the bone marrow [101,102]. Therefore, it is not surprising that the MC3T3 cells behave in a similar way on bone, as they likewise originate from the stromal cell lineage. As previously mentioned, the bone might be the most favorable substrate for the MC3T3 attachment explaining the results of this study. However, we demonstrate for the first time a sufficient cell adhesion and viability also on a thin HA layer prepared with the ALD method. The results offer new possibilities for developing better implant coatings leading to improved osseointegration and implant survival.

5. Conclusions

For the first time, this study demonstrates that osteoblast lineage MC3T3 cells attach to a thin atomic layer deposited HA on Ti substrate with focal adhesions as observed on glass slides and bone. This indicates cellular adhesion to the surface and shows that ALD-HA is biocompatible concerning cell attachment. However, no cell adhesion or morphology changes on FN-coated samples are observed, depicting that the ALD-HA surface is suitable for cellular adhesion without additional ECM protein coating. Cell viability on ALD-HA was comparable to viability on glass slides and bone. In conclusion, these results suggest that ALD-HA is a suitable coating for Ti-implants and can be further developed for obtaining improved implant solutions.

Author Contributions

Conceptualization, E.K. and J.T.; methodology, E.K. and J.T.; validation, E.K. and J.T.; formal analysis, E.K.; investigation, E.K.; resources, E.K. and F.A.; data curation, E.K.; writing—original draft preparation, E.K. and J.T.; writing—review and editing, E.K., J.H., F.A., M.R. and J.T.; visualization, E.K.; supervision, J.T.; project administration, J.T. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data that support the findings of this study are available on request from the corresponding author.

Acknowledgments

Biocenter Oulu Light Microscopy Core Facility and Biocenter Oulu Electron Microscopy Core Facility, University of Oulu, supported by Biocenter Finland, is acknowledged for their assistance with confocal and electron microscopic analysis.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Gao, X.; Fraulob, M.; Haïat, G. Biomechanical Behaviours of the Bone-Implant Interface: A Review. J. R. Soc. Interface 2019, 16, 20190259. [Google Scholar] [CrossRef] [PubMed]
  2. Kaur, M.; Singh, K. Review on Titanium and Titanium Based Alloys as Biomaterials for Orthopaedic Applications. Mater. Sci. Eng. C 2019, 102, 844–862. [Google Scholar] [CrossRef] [PubMed]
  3. Cai, S.; Wu, C.; Yang, W.; Liang, W.; Yu, H.; Liu, L. Recent Advance in Surface Modification for Regulating Cell Adhesion and Behaviors. Nanotechnol. Rev. 2020, 9, 971–989. [Google Scholar] [CrossRef]
  4. Chen, Y.F.; Goodheart, C.; Rua, D. The Body’s Cellular and Molecular Response to Protein-Coated Medical Device Implants: A Review Focused on Fibronectin and BMP Proteins. Int. J. Mol. Sci. 2020, 21, 8853. [Google Scholar] [CrossRef] [PubMed]
  5. Liu, X.; Chu, P.K.; Ding, C. Surface Modification of Titanium, Titanium Alloys, and Related Materials for Biomedical Applications. Mater. Sci. Eng. R Rep. 2004, 47, 49–121. [Google Scholar] [CrossRef] [Green Version]
  6. Strnad, Z.; Strnad, J.; Povýšil, C.; Urban, K. Effect of Plasma Sprayed Hydroxyapatite Coating on Osteoconductivity of Commercially Pure Titanium Implants. Int. J. Oral Maxillofac. Implant. 2000, 15, 483–490. [Google Scholar]
  7. Coathup, M.J.; Blunn, G.W.; Flynn, N.; Williams, C.; Thomas, N.P. A Comparison of Bone Remodelling around Hydroxyapatite-Coated, Porous-Coated and Grit-Blasted Hip Replacements Retrieved at Post-Mortem. J. Bone Jt. Surg. Br. 2001, 83, 118–123. [Google Scholar] [CrossRef]
  8. Hao, J.; Kuroda, S.; Ohya, K.; Bartakova, S.; Aoki, H.; Kasugai, S. Enhanced Osteoblast and Osteoclast Responses to a Thin Film Sputtered Hydroxyapatite Coating. J. Mater. Sci. Mater. Med. 2011, 22, 1489–1499. [Google Scholar] [CrossRef]
  9. Landor, I.; Vavrik, P.; Sosna, A.; Jahoda, D.; Hahn, H.; Daniel, M. Hydroxyapatite Porous Coating and the Osteointegration of the Total Hip Replacement. Arch. Orthop. Trauma Surg. 2007, 127, 81–89. [Google Scholar] [CrossRef]
  10. Ozawa, S.; Kasugai, S. Evaluation of Implant Materials (Hydroxyapatite, Glass-Ceramics, Titanium) in Rat Bone Marrow Stromal Cell Culture. Biomaterials 1996, 17, 23–29. [Google Scholar] [CrossRef]
  11. Wang, H.; Eliaz, N.; Xiang, Z.; Hsu, H.P.; Spector, M.; Hobbs, L.W. Early Bone Apposition in Vivo on Plasma-Sprayed and Electrochemically Deposited Hydroxyapatite Coatings on Titanium Alloy. Biomaterials 2006, 27, 4192–4203. [Google Scholar] [CrossRef] [PubMed]
  12. Suchanek, W.; Yoshimura, M. Processing and Properties of Hydroxyapatite-Based Biomaterials for Use as Hard Tissue Replacement Implants. J. Mater. Res. 1998, 13, 94–117. [Google Scholar] [CrossRef]
  13. Daugaard, H.; Elmengaard, B.; Bechtold, J.E.; Jensen, T.; Soballe, K. The Effect on Bone Growth Enhancement of Implant Coatings with Hydroxyapatite and Collagen Deposited Electrochemically and by Plasma Spray. J. Biomed. Mater. Res. Part A 2010, 92, 913–921. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Frayssinet, P.; Hardy, D.; Hanker, J.; Giammara, B. Natural History of Bone Response to Hydroxyapatite-Coated Hip Prostheses Implanted in Humans. Cells Mater. 1995, 5, 2. [Google Scholar]
  15. Oonishi, H.; Yamamoto, M.; Ishimaru, H.; Tsuji, E.; Kushitani, S.; Aono, M.; Ukon, Y. The Effect of Hydroxyapatite Coating on Bone Growth into Porous Titanium Alloy Implants. J. Bone Jt. Surg. Br. 1989, 71, 213–216. [Google Scholar] [CrossRef] [Green Version]
  16. Porter, A.E.; Hobbs, L.W.; Rosen, V.B.; Spector, M. The Ultrastructure of the Plasma-Sprayed Hydroxyapatite-Bone Interface Predisposing to Bone Bonding. Biomaterials 2002, 23, 725–733. [Google Scholar] [CrossRef]
  17. Mohedano, M.; Matykina, E.; Arrabal, R.; Pardo, A.; Merino, M.C. Metal Release from Ceramic Coatings for Dental Implants. Dent. Mater. 2014, 30, e28–e40. [Google Scholar] [CrossRef]
  18. Rahbek, O.; Lind, M.; Overgaard, S.; Søballe, K.; Bendix, K.; Bünger, C. Sealing Effect of Hydroxyapatite Coating on Peri-Implant Migration of Particles an Experimental Study in Dogs. J. Bone Jt. Surg. Br. 2001, 83, 441–447. [Google Scholar] [CrossRef]
  19. Sousa, S.R.; Barbosa, M.A. Effect of Hydroxyapatite Thickness on Metal Ion Release Fkom Ti6AMV Substrates. Biomaterials 1996, 17, 397–404. [Google Scholar] [CrossRef]
  20. Aebli, N.; Krebs, J.; Schwenke, D.; Stich, H.; Schwalder, P.; Theis, J.C. Degradation of Hydroxyapatite Coating on a Well-Functioning Femoral Component. J. Bone Jt. Surg. Ser. B 2003, 85, 499–503. [Google Scholar] [CrossRef] [Green Version]
  21. Overgaard, S.; Lind, M.; Josephsen, K.; Maunsbach, A.B.; Bü, C.; Søballe, K. Resorption of Hydroxyapatite and Fluorapatite Ceramic Coatings on Weight-Bearing Implants: A Quantitative and Morphological Study in Dogs. J. Biomed. Mater. Res. 1998, 39, 141–152. [Google Scholar] [CrossRef]
  22. Tonino, A.J.; Thèrin, M.; Doyle, C. Hydroxyapatite-Coated Femoral Stems. Histology and Histomorphometry around Five Components Retrieved at Post Mortem. J. Bone Jt. Surg. Br. Vol. 1999, 81, 148–154. [Google Scholar] [CrossRef]
  23. Tonino, A.; van der Wal, B.; Heyligers, I.; Grimm, B. Bone Remodeling and Hydroxyapatite Resorption in Coated Primary Hip Prostheses. Clin. Orthop. Relat. Res. 2009, 467, 478–484. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Yang, B.C.; Lee, J.W.; Ju, C.P.; Lin, J.H.C. Physical/Chemical Properties and Resorption Behavior of a Newly Developed Ca/P/S-Based Bone Substitute Material. Materials 2020, 13, 3458. [Google Scholar] [CrossRef]
  25. Haga, M.; Fujii, N.; Nozawa-Inoue, K.; Nomura, S.; Oda, K.; Uoshima, K.; Maeda, T. Detailed Process of Bone Remodeling after Achievement of Osseointegration in a Rat Implantation Model. Anat. Rec. 2009, 292, 38–47. [Google Scholar] [CrossRef]
  26. Müller-Mai, C.M.; Voigt, C. Incorporation and Degradation of Hydroxyapatite Implants of Incorporation and Degradation of Hydroxyapatite Implants of Different Surface Roughness and Surface Structure in Bone Different Surface Roughness and Surface Structure in Bone. Scanning Microsc. 1990, 4, 11. [Google Scholar]
  27. Wenisch, S.; Stahl, J.-P.; Horas, U.; Heiss, C.; Kilian, O.; Trinkaus, K.; Hild, A.; Schnettler, R. In Vivo Mechanisms of Hydroxyapatite Ceramic Degradation by Osteoclasts: Fine Structural Microscopy. J. Biomed. Mater. Res. 2003, 67A, 713–718. [Google Scholar] [CrossRef]
  28. Akiyama, N.; Takemoto, M.; Fujibayashi, S.; Neo, M.; Hirano, M.; Nakamura, T. Difference between Dogs and Rats with Regard to Osteoclast-like Cells in Calcium-Deficient Hydroxyapatite-Induced Osteoinduction. J. Biomed. Mater. Res. Part A 2011, 96, 402–412. [Google Scholar] [CrossRef] [Green Version]
  29. Kondo, N.; Ogose, A.; Tokunaga, K.; Umezu, H.; Arai, K.; Kudo, N.; Hoshino, M.; Inoue, H.; Irie, H.; Kuroda, K.; et al. Osteoinduction with Highly Purified β-Tricalcium Phosphate in Dog Dorsal Muscles and the Proliferation of Osteoclasts before Heterotopic Bone Formation. Biomaterials 2006, 27, 4419–4427. [Google Scholar] [CrossRef]
  30. Nasu, T.; Takemoto, M.; Akiyama, N.; Fujibayashi, S.; Neo, M.; Nakamura, T. EP4 Agonist Accelerates Osteoinduction and Degradation of P-Tricalcium Phosphate by Stimulating Osteoclastogenesis. J. Biomed. Mater. Res. Part A 2009, 89, 601–608. [Google Scholar] [CrossRef] [Green Version]
  31. Davison, N.L.; Gamblin, A.L.; Layrolle, P.; Yuan, H.; de Bruijn, J.D.; Barrère-de Groot, F. Liposomal Clodronate Inhibition of Osteoclastogenesis and Osteoinduction by Submicrostructured Beta-Tricalcium Phosphate. Biomaterials 2014, 35, 5088–5097. [Google Scholar] [CrossRef] [PubMed]
  32. Sabokbar, A.; Pandey, R.; Quinn, J.M.; Athanasou, N.A. Osteoclastic Differentiation by Mononuclear Phagocytes Containing Biomaterial Particles. Arch. Orthop. Trauma Surg. 1998, 117, 136–140. [Google Scholar] [CrossRef] [PubMed]
  33. Sabokbar, A.; Pandey, R.; Díaz, J.; Quinn, J.M.; Murray, D.W.; Athanasou, N.A. Hydroxyapatite Particles Are Capable of Inducing Osteoclast Formation. J. Mater. Sci. Mater. Med. 2001, 12, 659–664. [Google Scholar] [CrossRef] [PubMed]
  34. Pandey, R.; Quinn, J.; Joyner, C.; Murray, D.W.; Triffitt, J.T.; Athanasou, N.A. Arthroplasty Implant Biomaterial Particle Associated Macrophages Differentiate into Lacunar Bone Resorbing Cells. Ann. Rheum. Dis. 1996, 55. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  35. Murray, D.; Rushton, N. Macrophages Stimulate Bone Resorption When They Phagocytose Particles. J. Bone Jt. Surg. Br. 1990, 72, 988–992. [Google Scholar] [CrossRef] [Green Version]
  36. Jiranek, W.A.; Machado, M.; Jasty, M.; Jevsevar, D.; Wolfe, H.J.; Goldring, S.R.; Goldberg, M.J.; Harris, W.H. Production of Cytokines around Loosened Cemented Acetabular Components. Analysis with Immunohistochemical Techniques and in Situ Hybridization. J. Bone Jt. Surg. Am. Vol. 1993, 75, 863–879. [Google Scholar] [CrossRef]
  37. Bose, S.; Tarafder, S.; Bandyopadhyay, A. Hydroxyapatite Coatings for Metallic Implants. In Hydroxyapatite (Hap) for Biomedical Applications; Woodhead Publishing: Cambridge, UK, 2015; pp. 143–157. [Google Scholar]
  38. Faig-Martí, J.; Gil-Mur, F.J. Hydroxyapatite Coatings in Prosthetic Joints. Rev. Española De Cirugía Ortopédica Y Traumatol. 2008, 52, 113–120. [Google Scholar] [CrossRef]
  39. Sun, L.; Berndt, C.C.; Gross, K.A.; Kucuk, A. Material Fundamentals and Clinical Performance of Plasma-Sprayed Hydroxyapatite Coatings: A Review. J. Biomed. Mater. Res. 2001, 58, 570–592. [Google Scholar] [CrossRef]
  40. Oviroh, P.O.; Akbarzadeh, R.; Pan, D.; Coetzee, R.A.M.; Jen, T.C. New Development of Atomic Layer Deposition: Processes, Methods and Applications. Sci. Technol. Adv. Mater. 2019, 20, 465–496. [Google Scholar] [CrossRef] [Green Version]
  41. Liu, L.; Bhatia, R.; Webster, T.J. Atomic Layer Deposition of Nano-TiO2 Thin Films with Enhanced Biocompatibility and Antimicrobial Activity for Orthopedic Implants. Int. J. Nanomed. 2017, 12, 8711–8723. [Google Scholar] [CrossRef] [Green Version]
  42. Nazarov, D.V.; Zemtsova, E.G.; Valiev, R.Z.; Smirnov, V.M. Formation of Micro- and Nanostructures on the Nanotitanium Surface by Chemical Etching and Deposition of Titania Films by Atomic Layer Deposition (ALD). Materials 2015, 8, 8366–8377. [Google Scholar] [CrossRef] [PubMed]
  43. Smieszek, A.; Seweryn, A.; Marcinkowska, K.; Sikora, M.; Lawniczak-Jablonska, K.; Witkowski, B.S.; Kuzmiuk, P.; Godlewski, M.; Marycz, K. Titanium Dioxide Thin Films Obtained by Atomic Layer Deposition Promotes Osteoblasts’ Viability and Differentiation Potential While Inhibiting Osteoclast Activity—Potential Application for Osteoporotic Bone Regeneration. Materials 2020, 13, 4817. [Google Scholar] [CrossRef] [PubMed]
  44. Nazarov, D.V.; Smirnov, V.M.; Zemtsova, E.G.; Yudintceva, N.M.; Shevtsov, M.A.; Valiev, R.Z. Enhanced Osseointegrative Properties of Ultra-Fine-Grained Titanium Implants Modified by Chemical Etching and Atomic Layer Deposition. ACS Biomater. Sci. Eng. 2018, 4, 3268–3281. [Google Scholar] [CrossRef] [PubMed]
  45. Motola, M.; Capek, J.; Zazpe, R.; Bacova, J.; Hromadko, L.; Bruckova, L.; Ng, S.; Handl, J.; Spotz, Z.; Knotek, P.; et al. Thin TiO2 Coatings by ALD Enhance the Cell Growth on TiO2 Nanotubular and Flat Substrates. ACS Appl. Bio Mater. 2020, 3, 6447–6456. [Google Scholar] [CrossRef]
  46. Zemtsova, E.G.; Yudintceva, N.M.; Morozov, P.E.; Valiev, R.Z.; Smirnov, V.M.; Shevtsov, M.A. Improved Osseointegration Properties of Hierarchical Microtopographic/Nanotopographic Coatings Fabricated on Titanium Implants. Int. J. Nanomed. 2018, 13, 2175–2188. [Google Scholar] [CrossRef] [Green Version]
  47. Liang, X.; Lynn, A.D.; King, D.M.; Bryant, S.J.; Weimer, A.W. Biocompatible Interface Films Deposited within Porous Polymers by Atomic Layer Deposition (ALD). ACS Appl. Mater. Interfaces 2009, 1, 1988–1995. [Google Scholar] [CrossRef]
  48. Radtke, A.; Ehlert, M.; Jędrzejewski, T.; Sadowska, B.; Więckowska-Szakiel, M.; Holopainen, J.; Ritala, M.; Leskelä, M.; Bartmański, M.; Szkodo, M.; et al. Titania Nanotubes/Hydroxyapatite Nanocomposites Produced with the Use of the Atomic Layer Deposition Technique: Estimation of Bioactivity and Nanomechanical Properties. Nanomaterials 2019, 9, 123. [Google Scholar] [CrossRef] [Green Version]
  49. Seweryn, A.; Pielok, A.; Lawniczak-Jablonska, K.; Pietruszka, R.; Marcinkowska, K.; Sikora, M.; Witkowski, B.S.; Godlewski, M.; Marycz, K.; Smieszek, A. Zirconium Oxide Thin Films Obtained by Atomic Layer Deposition Technology Abolish the Anti-Osteogenic Effect Resulting from MiR-21 Inhibition in the Pre-Osteoblastic MC3T3 Cell Line. Int. J. Nanomed. 2020, 15, 1595–1610. [Google Scholar] [CrossRef] [Green Version]
  50. Jo, Y.; Kim, Y.T.; Cho, H.; Ji, M.K.; Heo, J.; Lim, H.P. Atomic Layer Deposition of ZrO2 on Titanium Inhibits Bacterial Adhesion and Enhances Osteoblast Viability. Int. J. Nanomed. 2021, 16, 1509–1523. [Google Scholar] [CrossRef]
  51. Astaneh, S.H.; Faverani, L.P.; Sukotjo, C.; Takoudis, C.G. Atomic Layer Deposition on Dental Materials: Processing Conditions and Surface Functionalization to Improve Physical, Chemical, and Clinical Properties—A Review. Acta Biomater. 2021, 121, 103–118. [Google Scholar] [CrossRef]
  52. Holopainen, J.; Kauppinen, K.; Mizohata, K.; Santala, E.; Mikkola, E.; Heikkilä, M.; Kokkonen, H.; Leskelä, M.; Lehenkari, P.; Tuukkanen, J.; et al. Preparation and Bioactive Properties of Nanocrystalline Hydroxyapatite Thin Films Obtained by Conversion of Atomic Layer Deposited Calcium Carbonate. Biointerphases 2014, 9, 031008. [Google Scholar] [CrossRef] [PubMed]
  53. Avila, I.; Pantchev, K.; Holopainen, J.; Ritala, M.; Tuukkanen, J. Adhesion and Mechanical Properties of Nanocrystalline Hydroxyapatite Coating Obtained by Conversion of Atomic Layer-Deposited Calcium Carbonate on Titanium Substrate. J. Mater. Sci. Mater. Med. 2018, 29, 111. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  54. Nilsen, O.; Fjellvåg, H.; Kjekshus, A. Growth of Calcium Carbonate by the Atomic Layer Chemical Vapour Deposition Technique. Thin Solid Film. 2004, 450, 240–247. [Google Scholar] [CrossRef]
  55. Wang, L.; Zeng, X.; Yan, G.; Chen, X.; Luo, K.; Zhou, S.; Zhang, P.; Li, J.; Wong, T.W. Biomimetic Scaffolds with Programmable Pore Structures for Minimum Invasive Bone Repair. Nanoscale 2021, 13, 16680–16689. [Google Scholar] [CrossRef] [PubMed]
  56. Li, Y.; Li, B.; Song, Y.; Ma, A.; Li, C.; Zhang, X.; Li, H.; Zhang, Q.; Zhang, K. Improved Osteoblast Adhesion and Osseointegration on TiO2 Nanotubes Surface with Hydroxyapatite Coating. Dent. Mater. J. 2019, 38, 278–286. [Google Scholar] [CrossRef] [Green Version]
  57. Gu, Y.X.; Du, J.; Zhao, J.M.; Si, M.S.; Mo, J.J.; Lai, H.C. Characterization and Preosteoblastic Behavior of Hydroxyapatite-Deposited Nanotube Surface of Titanium Prepared by Anodization Coupled with Alternative Immersion Method. J. Biomed. Mater. Res. Part B Appl. Biomater. 2012, 100B, 2122–2130. [Google Scholar] [CrossRef]
  58. Mei, S.; Dong, F.-S.; Li, X.-C.; Feng, Y.-C. Effect of Biomineralization on the Proliferation and Differentiation of MC3T3-E1 Cells Grown on a Titanium Surface. Int. J. Clin. Exp. Med. 2018, 11, 12983–12990. [Google Scholar]
  59. Persson, M.; Lorite, G.S.; Kokkonen, H.E.; Cho, S.W.; Lehenkari, P.P.; Skrifvars, M.; Tuukkanen, J. Effect of Bioactive Extruded PLA/HA Composite Films on Focal Adhesion Formation of Preosteoblastic Cells. Colloids Surf. B Biointerfaces 2014, 121, 409–416. [Google Scholar] [CrossRef]
  60. Kobayashi, M.; Nihonmatsu, S.; Okawara, T.; Onuki, H.; Sakagami, H.; Nakajima, H.; Takeishi, H.; Shimada, J. Adhesion and Proliferation of Osteoblastic Cells on Hydroxyapatite-Dispersed Ti-Based Composite Plate. Vivo 2019, 33, 1067–1079. [Google Scholar] [CrossRef] [Green Version]
  61. Bays, J.L.; DeMali, K.A. Vinculin in Cell–Cell and Cell–Matrix Adhesions. Cell. Mol. Life Sci. 2017, 74, 2999–3009. [Google Scholar] [CrossRef] [Green Version]
  62. Cooper, L.F.; Handelman, B.; Mccormack, S.M.; Guckes, A.D. Binding of Murine Osteoblastic Cells to Titanium Disks and Collagen I Gels: Implications for Alternative Interpretations of Osseointegration. Int. J. Oral Maxillofac. Implant. 1993, 8, 264–272. [Google Scholar]
  63. Hayakawa, T.; Yoshida, E.; Yoshimura, Y.; Uo, M.; Yoshinari, M. MC3T3-E1 Cells on Titanium Surfaces with Nanometer Smoothness and Fibronectin Immobilization. Int. J. Biomater. 2012, 2012, 743465. [Google Scholar] [CrossRef] [PubMed]
  64. Pugdee, K.; Shibata, Y.; Yamamichi, N.; Tsutsumi, H.; Yoshinari, M.; Abiko, Y.; Hayakawa, T. Gene Expression of MC3T3-E1 Cells on Fibronectin-Immobilized Titanium Using Tresyl Chloride Activation Technique. Dent. Mater. J. 2007, 26, 647–655. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  65. Pramono, S.; Pugdee, K.; Suwanprateep, J.; Koontongkaew, S. Sandblasting and Fibronectin-Derived Peptide Immobilization on Titanium Surface Increase Adhesion and Differentiation of Osteoblast-like Cells (MC3T3-E1). J. Dent. Sci. 2016, 11, 427–436. [Google Scholar] [CrossRef] [Green Version]
  66. Yoshida, E.; Yoshimura, Y.; Uo, M.; Yoshinari, M.; Hayakawa, T. Influence of Nanometer Smoothness and Fibronectin Immobilization of Titanium Surface on MC3T3-E1 Cell Behavior. J. Biomed. Mater. Res. Part A 2012, 100A, 1556–1564. [Google Scholar] [CrossRef]
  67. Noh, R.; Im, Y.; Lee, E.Y.; Jang, H.N.; Dung, T.D.; Kim, M.S.; Yoo, H. Comparison of Surface Roughness Effects upon the Attachment of Osteoblastic Progenitor MC3T3-E1 Cells and Inflammatory RAW 264.7 Cells to a Titanium Disc. Int. J. Oral Biol. 2009, 34, 37–42. [Google Scholar]
  68. Kim, S.; Myung, W.C.; Lee, J.S.; Cha, J.K.; Jung, U.W.; Yang, H.C.; Lee, I.S.; Choi, S.H. The Effect of Fibronectin-Coated Implant on Canine Osseointegration. J. Periodontal Implant Sci. 2011, 41, 242–247. [Google Scholar] [CrossRef] [Green Version]
  69. Wennerberg, A.; Albrektsson, T. Effects of Titanium Surface Topography on Bone Integration: A Systematic Review. Clin. Oral Implant. Res. 2009, 20, 172–184. [Google Scholar] [CrossRef]
  70. Wang, Q.; Zhou, P.; Liu, S.; Attarilar, S.; Ma, R.L.W.; Zhong, Y.; Wang, L. Multi-Scale Surface Treatments of Titanium Implants for Rapid Osseointegration: A Review. Nanomaterials 2020, 10, 1244. [Google Scholar] [CrossRef]
  71. Nobles, K.P.; Janorkar, A.V.; Williamson, R.S. Surface Modifications to Enhance Osseointegration–Resulting Material Properties and Biological Responses. J. Biomed. Mater. Res. Part B Appl. Biomater. 2021, 109, 1909–1923. [Google Scholar] [CrossRef]
  72. Zhao, L.; Mei, S.; Chu, P.K.; Zhang, Y.; Wu, Z. The Influence of Hierarchical Hybrid Micro/Nano-Textured Titanium Surface with Titania Nanotubes on Osteoblast Functions. Biomaterials 2010, 31, 5072–5082. [Google Scholar] [CrossRef] [PubMed]
  73. Gittens, R.A.; McLachlan, T.; Olivares-Navarrete, R.; Cai, Y.; Berner, S.; Tannenbaum, R.; Schwartz, Z.; Sandhage, K.H.; Boyan, B.D. The Effects of Combined Micron-/Submicron-Scale Surface Roughness and Nanoscale Features on Cell Proliferation and Differentiation. Biomaterials 2011, 32, 3395–3403. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  74. Gittens, R.A.; Olivares-Navarrete, R.; McLachlan, T.; Cai, Y.; Hyzy, S.L.; Schneider, J.M.; Schwartz, Z.; Sandhage, K.H.; Boyan, B.D. Differential Responses of Osteoblast Lineage Cells to Nanotopographically-Modified, Microroughened Titanium-Aluminum-Vanadium Alloy Surfaces. Biomaterials 2012, 33, 8986–8994. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  75. Long, E.G.; Buluk, M.; Gallagher, M.B.; Schneider, J.M.; Brown, J.L. Human Mesenchymal Stem Cell Morphology, Migration, and Differentiation on Micro and Nano-Textured Titanium. Bioact. Mater. 2019, 4, 249–255. [Google Scholar] [CrossRef]
  76. Zhou, P.; Mao, F.; He, F.; Han, Y.; Li, H.; Chen, J.; Wei, S. Screening the Optimal Hierarchical Micro/Nano Pattern Design for the Neck and Body Surface of Titanium Implants. Colloids Surf. B Biointerfaces 2019, 178, 515–524. [Google Scholar] [CrossRef]
  77. Zhang, Z.; Xu, R.; Yang, Y.; Liang, C.; Yu, X.; Liu, Y.; Wang, T.; Yu, Y.; Deng, F. Micro/Nano-Textured Hierarchical Titanium Topography Promotes Exosome Biogenesis and Secretion to Improve Osseointegration. J. Nanobiotechnology 2021, 19, 78. [Google Scholar] [CrossRef]
  78. Bai, L.; Chen, P.; Zhao, Y.; Hang, R.; Yao, X.; Tang, B.; Liu, C.; Xiao, Y.; Hang, R. A Micro/Nano-Biomimetic Coating on Titanium Orchestrates Osteo/Angio-Genesis and Osteoimmunomodulation for Advanced Osseointegration. Biomaterials 2021, 278, 121162. [Google Scholar] [CrossRef]
  79. Wu, C.; Chen, M.; Zheng, T.; Yang, X. Effect of Surface Roughness on the Initial Response of MC3T3-E1 Cells Cultured on Polished Titanium Alloy. Bio-Med. Mater. Eng. 2015, 26, S155–S164. [Google Scholar] [CrossRef] [Green Version]
  80. Linez-Bataillon, P.; Monchau, F.; Bigerelle, M.; Hildebrand, H.F. In Vitro MC3T3 Osteoblast Adhesion with Respect to Surface Roughness of Ti6Al4V Substrates. Biomol. Eng. 2002, 19, 133–141. [Google Scholar] [CrossRef]
  81. Le Guehennec, L.; Lopez-Heredia, M.A.; Enkel, B.; Weiss, P.; Amouriq, Y.; Layrolle, P. Osteoblastic Cell Behaviour on Different Titanium Implant Surfaces. Acta Biomater. 2008, 4, 535–543. [Google Scholar] [CrossRef]
  82. Lu, H.-K. Regulation of Pre-Osteoblast Osteogenic Transcription Factors by Different Titanium Surface Topography. J. Dent. Health Oral Disord. Ther. 2017, 8, 482–486. [Google Scholar] [CrossRef]
  83. Iwaya, Y.; Machigashira, M.; Kanbara, K.; Miyamoto, M.; Noguchi, K.; Izumi, Y.; Ban, S. Surface Properties and Biocompatibility of Acid-Etched Titanium. Dent. Mater. J. 2008, 27, 415–421. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  84. Migita, S.; Araki, K. Effect of Nanometer Scale Surface Roughness of Titanium for Osteoblast Function. AIMS Bioeng. 2017, 4, 162–170. [Google Scholar] [CrossRef]
  85. Migita, S.; Yamaguchi, T. Initial Adhesion Behavior of Osteoblast on Titanium with Sub-Micron Scale Roughness. Recent Prog. Mater. 2019, 2, 1. [Google Scholar] [CrossRef] [Green Version]
  86. Lumetti, S.; Manfredi, E.; Ferraris, S.; Spriano, S.; Passeri, G.; Ghiacci, G.; Macaluso, G.; Galli, C. The Response of Osteoblastic MC3T3-E1 Cells to Micro- and Nano-Textured, Hydrophilic and Bioactive Titanium Surfaces. J. Mater. Sci. Mater. Med. 2016, 27, 68. [Google Scholar] [CrossRef] [PubMed]
  87. Liu, J.; Jin, M.; Zhang, Z.; Wu, L.; Jin, X.; Zhang, C.; Xing, Y. Effects of Titanium Micro-Nanopermeable Structures on Osteogenic Differentiation. J. Nanomater. 2018, 2018, 7083416. [Google Scholar] [CrossRef]
  88. Sunarso; Toita, R.; Tsuru, K.; Ishikawa, K. Immobilization of Calcium and Phosphate Ions Improves the Osteoconductivity of Titanium Implants. Mater. Sci. Eng. C 2016, 68, 291–298. [Google Scholar] [CrossRef] [PubMed]
  89. Taniguchi, Y.; Kakura, K.; Yamamoto, K.; Kido, H.; Yamazaki, J. Accelerated Osteogenic Differentiation and Bone Formation on Zirconia with Surface Grooves Created with Fiber Laser Irradiation. Clin. Implant. Dent. Relat. Res. 2016, 18, 883–894. [Google Scholar] [CrossRef] [PubMed]
  90. Horiguchi, Y.; Nakai, T.; Kume, K. Effects of Bordetella Bronchiseptica Dermonecrotic Toxin on the Structure and Function of Osteoblastic Clone MC3T3-E1 Cells. Infect. Immun. 1991, 59, 1112–1116. [Google Scholar] [CrossRef] [Green Version]
  91. Zhu, Z.; Xie, Q.; Huang, Y.; Zhang, S.; Chen, Y. Aucubin Suppresses Titanium Particles-Mediated Apoptosis of MC3T3-E1 Cells and Facilitates Osteogenesis by Affecting the BMP2/Smads/RunX2 Signaling Pathway. Mol. Med. Rep. 2018, 18, 2561–2570. [Google Scholar] [CrossRef] [Green Version]
  92. Terada, M.; Abe, S.; Akasaka, T.; Uo, M.; Kitagawa, Y.; Watari, F. Multiwalled Carbon Nanotube Coating on Titanium. Bio-Med. Mater. Eng. 2009, 19, 45–52. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  93. Matsumoto, T.; Kawakami, M.; Kuribayashi, K.; Takenaka, T.; Minamide, A.; Tamaki, T. Effects of Sintered Bovine Bone on Cell Proliferation, Collagen Synthesis, and Osteoblastic Expression in MC3T3-E1 Osteoblast-like Cells. J. Orthop. Res. 1999, 17, 586–592. [Google Scholar] [CrossRef] [PubMed]
  94. Caplan, A.I. Mesenchymal Stem Cells. J. Orthop. Res. Off. Publ. Orthop. Res. Soc. 1991, 9, 641–650. [Google Scholar] [CrossRef] [PubMed]
  95. Rasini, V.; Dominici, M.; Kluba, T.; Siegel, G.; Lusenti, G.; Northoff, H.; Horwitz, E.M.; Schäfer, R. Mesenchymal Stromal/Stem Cells Markers in the Human Bone Marrow. Cytotherapy 2013, 15, 292–306. [Google Scholar] [CrossRef]
  96. Dominici, M.; le Blanc, K.; Mueller, I.; Slaper-Cortenbach, I.; Marini, F.; Krause, D.; Deans, R.; Keating, A.; Prockop, D.; Horwitz, E. Minimal Criteria for Defining Multipotent Mesenchymal Stromal Cells. The International Society for Cellular Therapy Position Statement. Cytotherapy 2006, 8, 315–317. [Google Scholar] [CrossRef]
  97. Klimczak, A.; Kozlowska, U. Mesenchymal Stromal Cells and Tissue-Specific Progenitor Cells: Their Role in Tissue Homeostasis. Stem Cells Int. 2016, 2016, 4285215. [Google Scholar] [CrossRef] [Green Version]
  98. Kylmäoja, E.; Nakamura, M.; Turunen, S.; Patlaka, C.; Andersson, G.; Lehenkari, P.; Tuukkanen, J. Peripheral Blood Monocytes Show Increased Osteoclast Differentiation Potential Compared to Bone Marrow Monocytes. Heliyon 2018, 4, e00780. [Google Scholar] [CrossRef] [Green Version]
  99. Kylmäoja, E.; Kokkonen, H.; Kauppinen, K.; Hussar, P.; Sato, T.; Haugan, K.; Larsen, B.D.; Tuukkanen, J. Osteoclastogenesis Is Influenced by Modulation of Gap Junctional Communication with Antiarrhythmic Peptides. Calcif. Tissue Int. 2013, 92, 270–281. [Google Scholar] [CrossRef]
  100. Hauge, E.M.; Qvesel, D.; Eriksen, E.F.; Mosekilde, L.; Melsen, F. Cancellous Bone Remodeling Occurs in Specialized Compartments Lined by Cells Expressing Osteoblastic Markers. J. Bone Miner. Res. 2001, 16, 1575–1582. [Google Scholar] [CrossRef]
  101. Bi, L.X.; Simmons, D.J.; Hawkins, H.K.; Cox, R.A.; Mainous, E.G. Comparative Morphology of the Marrow Sac. Anat. Rec. 2000, 260, 410–415. [Google Scholar] [CrossRef]
  102. Kristensen, H.B.; Andersen, T.L.; Marcussen, N.; Rolighed, L.; Delaisse, J.-M. Osteoblast Recruitment Routes in Human Cancellous Bone Remodeling. Am. J. Pathol. 2014, 184, 778–789. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Figure 1. Morphology and viability of MC3T3-cells on cover glass, ALD-HA and bone. (A) FESEM images of MC3T3 cells cultured on cover glass, ALD-HA, FN-coated ALD-HA and bone (representative data from one culture). The cells were cultured for 48 h. The samples were evenly covered with cells, and the cells seemed to attach to the surface with focal adhesion-like structures. Magnification: 150× (left panel), 2500× (center panel) and 5000× (right panel). (B) Morphology of one MC3T3 cell cultured on ALD-HA. Magnification 2500×. (C) MTT test results of MC3T3 cells cultured on cover glass, bone slices and ALD-HA. MTT test was performed after 48 h cell culture on the samples. Cell viability on bone slices and ALD-HA samples was compared to cover glasses, which were treated as controls by setting their viability to 100%. The data is pooled from three independent cell cultures and shown as mean ± SEM. *** p <0.001.
Figure 1. Morphology and viability of MC3T3-cells on cover glass, ALD-HA and bone. (A) FESEM images of MC3T3 cells cultured on cover glass, ALD-HA, FN-coated ALD-HA and bone (representative data from one culture). The cells were cultured for 48 h. The samples were evenly covered with cells, and the cells seemed to attach to the surface with focal adhesion-like structures. Magnification: 150× (left panel), 2500× (center panel) and 5000× (right panel). (B) Morphology of one MC3T3 cell cultured on ALD-HA. Magnification 2500×. (C) MTT test results of MC3T3 cells cultured on cover glass, bone slices and ALD-HA. MTT test was performed after 48 h cell culture on the samples. Cell viability on bone slices and ALD-HA samples was compared to cover glasses, which were treated as controls by setting their viability to 100%. The data is pooled from three independent cell cultures and shown as mean ± SEM. *** p <0.001.
Biomolecules 12 00654 g001
Figure 2. Focal adhesion localization in MC3T3 cells. Focal adhesion staining of MC3T3 cells on cover glass, ALD-HA and bone slice after 48h culture (representative data from one culture). Nuclei were stained with Hoechst 33258 (blue), focal adhesions with anti-vinculin (green) and actin cytoskeleton with TRITC-phalloidin (red). Images were taken with fluorescence microscope and 63× objective with 1.48 zoom, and maximum intensity projections were created from Z-stacks. Cover glasses and ALD-HA samples were either non-coated or coated with fibronectin (FN). Focal adhesion-like structures were present at the edges of the cells on all surfaces, although on ALD-HA and bone these structures were thinner (arrows) compared to thicker dot-like structures observed on cover glass (arrowheads). Fibronectin coating did not have an effect on the cell morphology or vinculin staining.
Figure 2. Focal adhesion localization in MC3T3 cells. Focal adhesion staining of MC3T3 cells on cover glass, ALD-HA and bone slice after 48h culture (representative data from one culture). Nuclei were stained with Hoechst 33258 (blue), focal adhesions with anti-vinculin (green) and actin cytoskeleton with TRITC-phalloidin (red). Images were taken with fluorescence microscope and 63× objective with 1.48 zoom, and maximum intensity projections were created from Z-stacks. Cover glasses and ALD-HA samples were either non-coated or coated with fibronectin (FN). Focal adhesion-like structures were present at the edges of the cells on all surfaces, although on ALD-HA and bone these structures were thinner (arrows) compared to thicker dot-like structures observed on cover glass (arrowheads). Fibronectin coating did not have an effect on the cell morphology or vinculin staining.
Biomolecules 12 00654 g002
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Kylmäoja, E.; Holopainen, J.; Abushahba, F.; Ritala, M.; Tuukkanen, J. Osteoblast Attachment on Titanium Coated with Hydroxyapatite by Atomic Layer Deposition. Biomolecules 2022, 12, 654. https://doi.org/10.3390/biom12050654

AMA Style

Kylmäoja E, Holopainen J, Abushahba F, Ritala M, Tuukkanen J. Osteoblast Attachment on Titanium Coated with Hydroxyapatite by Atomic Layer Deposition. Biomolecules. 2022; 12(5):654. https://doi.org/10.3390/biom12050654

Chicago/Turabian Style

Kylmäoja, Elina, Jani Holopainen, Faleh Abushahba, Mikko Ritala, and Juha Tuukkanen. 2022. "Osteoblast Attachment on Titanium Coated with Hydroxyapatite by Atomic Layer Deposition" Biomolecules 12, no. 5: 654. https://doi.org/10.3390/biom12050654

APA Style

Kylmäoja, E., Holopainen, J., Abushahba, F., Ritala, M., & Tuukkanen, J. (2022). Osteoblast Attachment on Titanium Coated with Hydroxyapatite by Atomic Layer Deposition. Biomolecules, 12(5), 654. https://doi.org/10.3390/biom12050654

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop